OpGen > Investor Relations > Overview


Webcast ImageWebcast
Q3 2016 OpGen Inc Earnings Conference Call (Replay)
10/24/16 at 4:30 p.m. ET
Q3 2016 OpGen Inc Earnings Conference Call
Monday, October 24, 2016 4:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

OpGen, Inc. is an early commercial stage company using molecular testing and bioinformatics to assist healthcare providers to combat multi-drug resistant bacterial infections. The company’s products and services are designed to enable the rapid identification of hospital patients who are colonized or infected with life-threatening, multi-drug resistant organisms, or MDROs. The company’s lead product is the Acuitas® MDRO Gene Test. Products in development include the Acuitas Lighthouse™ MDRO Management System and the Acuitas Resistome Test. In addition, the company has more than 10 years of experience mapping microbial, plant and human genomes.

Upcoming Events

Wednesday, October 26, 2016 through Sunday, October 30, 2016

More Events

OPGN (Common Stock)
Exchange :NASDAQ CM (US Dollar)
Financial Status IndicatorC
Price :$1.76
Change : Stock is Up 0.05 (0.00%)
Volume :202,458
Data as of 10/24/16 4:00 p.m. ET
Minimum 20 minute delay
Data Provided by Thomson Reuters